We offer tailored partnerships to support and transform drug discovery.

Every collaboration is a bespoke arrangement, meticulously designed to discover new compounds and targets in patient relevant disease models.

MIMETAS offers flexible fee-for-service solutions for therapy prioritization, optimization, and de-risking of compounds.

As an extension of your team, MIMETAS provides the expertise and resources needed for effective research and development.

Our OrganoReady program is made for you when you need optimized assays for investigational toxicology.

We guarantee OrganoReady performance according to specifications, in a fast and convenient sales transaction with a clear fee structure.

Giving you some food for thought. Read our blogs to learn more about 3D tissue culture, research backgrounds, developments, and its future outlook.

Get inspired by research done by our scientists, partners, and customers around the globe.

Learn about our mission, vision, the history of the company, and find out what we mean with MIMETAS-do.

Explore our app notes & whitepapers

3D Immune Cell Migration

3D Immune Cell Migration
In collaboration with Molecular Devices

A 3D human blood-brain barrier model in a high throughput platform for disease modeling and drug development

Automation of an organ-on-a-chip assay: automated culture, imaging, and analysis of angiogenesis

Building a high-throughput and automated liver-on-a-chip model for hepatotoxicity detection

Comparison of the OrganoPlate® and the Transwell® platform for in vitro intestinal permeability assays

High-Content Assay for Morphological Characterization of 3D Neuronal Networks in a Microfluidic Platform (collaboration with Molecular Devices).

High-Throughput Toxicity Assessment in OrganoReady® Blood Vessel HUVEC

Human renal proximal tubule-on-a-chip for nephrotoxicity and drug interaction studies

Investigating the hallmarks of inflammatory bowel disease (IBD) in a 3D perfused multicellular intestine-on-a-chip model

Perfused 3D angiogenic sprouting in a high-throughput in vitro platform

Predicting gastrointestinal toxicity using adult stem cell-derived OrganoReady Colon Organoid with functional multiplexed assays

NEW Predicting gastrointestinal toxicity using adult stem cell-derived OrganoReady^® Colon Organoid with functional multiplexed assays

Transendothelial Migration of T Cells in A Microfluidic 3D Endothelium-on-a-Chip Model

Whitepaper: Advancing Immunology Drug Discovery with 3D Tissue Models

NEW Whitepaper: Advancing Immunology Drug Discovery with 3D Tissue Models

Whitepaper: Closing the Translational Gap in Cancer Drug Discovery with Comprehensive Tumor Models

Whitepaper: High-throughput phenotypic screening with Organ-on-a-chip: a perfused 3D microfluidic angiogenesis assay

Cookies